Clinical Trials in Georgia

Showing 1761-1780 of 19,050 trials

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

NCT06056011

The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.

Febrile Illness

Baxter Healthcare Corporation373 participantsStarted Feb 2024

Fayetteville, Georgia, United States • Mankato, Minnesota, United States • Buffalo, New York, United States +2 more locations

RECRUITINGPhase 363 miles

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

NCT05304767

This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inadequate response to their current antipsychotic treatment who previously completed the treatment period (Visit 8/Day 42 ± 3) of ARISE Study (KAR-012). The primary objective of the study is to assess the long-term safety and tolerability of adjunctive KarXT (a fixed dose combination of xanomeline and trospium chloride twice daily \[BID\]) in subjects with schizophrenia.

Schizophrenia

Karuna Therapeutics, Inc., a Bristol Myers Squibb company280 participantsStarted Mar 2022

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +172 more locations

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Find Trials by Condition in Georgia

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

AMPLATZER PFO Occluder Post Approval Study

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

Secukinumab Open Label Roll-over Extension Protocol

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Suubi4Stigma: Addressing HIV-Associated Stigma Among Adolescents

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening